EN DE
STOCK COMPARISON

Laobaixing Pharmacy vs Jd Health International Inc: Fair Value & Quality

Both stocks run through our valuation models. Here is how Laobaixing Pharmacy (603883) and Jd Health International Inc (6618) compare, as of Sep 5, 2026.

As of Sep 5, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: Laobaixing Pharmacy trades at ¥13.47 versus a fair value of ¥10.57 (-22%), while Jd Health International Inc trades at HK$37.06 versus HK$33.31 (-10%).
Laobaixing Pharmacy
603883.SHG · CNY · Consumer Staples
-22%
upside to fair value
overvalued
Price¥13.47
Fair Value¥10.57
Quality58/100
Jd Health International Inc
6618.HK · HKD · Health Care
-10%
upside to fair value
overvalued
PriceHK$37.06
Fair ValueHK$33.31
Quality72/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Laobaixing PharmacyJd Health International Inc
Valuation
24.5×P/E (TTM)17.6×
0.43×P/S (TTM)1.48×
1.48×P/B1.81×
6.1×EV/EBITDA19.4×
—PEG1.26×
−21.5%Fair value upside−10.1%
3.0%Dividend yield—
¥0.41Dividend per share—
Profitability
8%Operating margin4%
0.74×EBIT margin trend (5Y)—
8%Return on equity9%
3%Return on assets3%
Growth
1%Revenue growth (YoY)28%
3.3%Avg. growth/yr (3Y)16.3%
9.7%Avg. growth/yr (5Y)30.5%
−0.5%Value creation/yr+61.5%
Balance & size
8.8×Interest coverage (EBIT/interest)342.2×
0.22×Debt / equity—
$1BMarket cap$14B
mixedGrowth qualityhealthy
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

Jd Health International Inc leads: 1 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Laobaixing Pharmacyof which business quality 59 · market factors 45 Jd Health International Incof which business quality 74 · market factors 22
ProfitabilityMargins and returns on capital today
46
47
Quality GrowthAre margins and returns improving?
48
80
CashflowEarnings quality: real cash, not paper profit
77
76
Fin. StrengthBalance sheet, leverage, solvency risk
50
100
InvestmentDisciplined investing over empire-building
100
66
Low VolatilityCalm price path (market factor)
86
44
MomentumPrice trend over the last 3–12 months (market factor)
34
16
52W MomentumDistance to the 52-week high (market factor)
19
7
Net IssuanceBuybacks instead of dilution
43
73

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyLaobaixing PharmacyPrice ¥13.47Jd Health International IncPrice HK$37.06
DCF Models+292%above the price¥52.85+90%above the priceHK$70.32
Earnings-Based-20%below the price¥10.76+38%above the priceHK$51.28
Dividend Discount-64%below the price¥4.83n/a
Multiples+17%above the price¥15.70-23%below the priceHK$28.65
Asset-Based-57%below the price¥5.77-66%below the priceHK$12.62
Growth DCF+408%above the price¥68.49+110%above the priceHK$77.68
Economic Profit-4%close to the price¥12.93-44%below the priceHK$20.89
Growth Earnings-15%close to the price¥11.45+89%above the priceHK$70.00
Minimum-64%below the price¥4.83-66%below the priceHK$12.62
Maximum+408%above the price¥68.49+110%above the priceHK$77.68
Median-10%close to the price¥12.19+38%above the priceHK$51.28
Geometric mean+11%close to the price¥14.97+6%close to the priceHK$39.43

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Laobaixing Pharmacy: 10 of 26 models see the stock below the current price.

Jd Health International Inc: 9 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Laobaixing Pharmacy
Bear ¥7.92Fair Value ¥10.57Bull ¥13.21
¥13.47 = current price (white tick)
Jd Health International Inc
Bear HK$25.38Fair Value HK$33.31Bull HK$39.19
HK$37.06 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Laobaixing Pharmacy · Consumer Staples

Quality score58 · above median
Fair value upside-22% · below median

Jd Health International Inc · Health Care

Quality score72 · Top 25%
Fair value upside-10% · above median

Bottom line

As of Sep 5, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: Laobaixing Pharmacy trades at ¥13.47 versus a fair value of ¥10.57 (-22%), while Jd Health International Inc trades at HK$37.06 versus HK$33.31 (-10%).

Jd Health International Inc has the higher quality score (72/100).

See the full analysis →
Laobaixing Pharmacy · Jd Health International Inc

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Laobaixing Pharmacy

Altria vs WalmartCostco Wholesale vs AltriaCoca-Cola vs AltriaAltria vs Procter & Gamble

Related to Jd Health International Inc

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupMerck & Company vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.